Navigation Links
Country economy is a stronger predictor of therapy initiation
Date:6/18/2010

Rome, Italy, Friday 18 June 2010: There is significant disparity between 'richer' and 'poorer' countries in terms of access to biological treatments for rheumatoid arthritis (RA), according to results from a multinational study across four continents presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. Furthermore, findings from a separate study show that RA patients report the severity of their disease in the same way, irrespective of the country where they live.

Results of a multinational study assessing whether macro-economic differences predict likelihood of treatment with a biologic showed that at the start of the study, RA patients in rich countries were three times more likely to have already received a biologic than those in poor countries (33% vs. 11.6%). Assessing the number of patients who had not received a biologic before the start of the study showed that the disparity between patients in rich and poor countries (20% vs. 14%) continued in the following four to five years.

Results of a second study showed that macro-economic status did not have an impact on RA patients' perceptions of their disease severity, as measured by several clinical measures collated within the Patient Reported Outcomes (PROs) index. PROs were compared to the DAS measure of disease activity (DAS28) and a significant association for both rich and poor countries was (beta coefficient 0.73 (0.70-0.77) vs. 0.78 (0.73-0.82) respectively) detected. This indicates that, regardless of macro-economic status of the country, patients in the study report disease severity in a consistent way.

"The QUEST-RA study involves researchers and patients from 32 countries worldwide, and is the first of this scale to reveal some interesting findings related to the impact of countries' macro-economic status on patients' perceptions of disease, as well as the healthcare options available to them," said Dr. Tuulikki Sokka, Jyvskyl Central Hospital, Jyvskyl, Finland and lead author of both analyses. "Our study group, QUEST-RA, was put together as a collaborative international study of RA and consequently, it sheds light on the true international variations and related economic factors that affect the treatment of RA across the world."

Professor Paul Emery, President of EULAR and arc Professor of Rheumatology, Leeds Institute of Molecular Medicine, University of Leeds, UK said "The results of these studies have painted a clear picture of the impact that macro-economy of the country has on the treatments available for patients. EULAR is a partnership organisation of people with arthritis and rheumatism in Europe and clinicians, researchers, health professionals and will continue to work for equal access to effective treatments across Europe."

Study design

The multinational study (SAT0515) assessed 3,394 RA patients (80% female, mean age 57 years) from 18 countries (11 rich, 7 poor) who had 4-5 year follow up data available for review, using the QUEST-RA database which includes patient data from 86 sites in 32 countries.

The second study (SAT0051) utilized all available data from 8,039 patients from the QUEST-RA database, (16 rich countries, 16 poor). PROs including measures to assess HAQ and visual analogue scales for pain (including the Routine Assessment of Patient Index Data3 (RAPID3) and Disease Activity Score (DAS28)) were used to gain feedback direct from the patient on the physical function limitations and experience of pain associated with their condition.


'/>"/>

Contact: Rory Berrie
eularpressoffice@uk.cohnwolfe.com
44-790-151-3297
European League Against Rheumatism
Source:Eurekalert

Related medicine news :

1. Online Services Will Energise The Country's Invisible Healthcare Service
2. Just Graduated College Seniors Ride for Loved Ones With Diabetes Cycling Cross Country to Raise Funds to Help Find a Cure
3. Rollerbladers Finish Grueling Cross Country Trek Helped by Tahitian Noni Products
4. AFOP's SAFE AmeriCorps Collecting Clothes for Our Country's Farmworkers
5. Leading New Mexico Resort Spa At Hyatt Regency Tamaya Ranked Among The Country's Best By Conde Nast Traveler
6. 9-country study shows wide variations in how women with early breast cancer are treated
7. NJ Medical Director Travels To Haiti's Bush Country
8. A Monumentally Important Victory for Our Country
9. UniCare, Power Country 105.9 Hold Nursery Drive for the Beckley Dream Center
10. In a Cross-Country Comeback, Skier With Type 1 Diabetes Named to U.S. Olympic Team
11. In a Cross-Country Comeback, Skier With Type 1 Diabetes Named to U.S. Olympic Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
Breaking Medicine Technology: